相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group
Vasiliki Nikolaou et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors
Paola Cutroneo et al.
DERMATOLOGIC THERAPY (2021)
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian et al.
LANCET (2021)
Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer
Deniz C. Guven et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2020)
Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis
Jarish N. Cohen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Severe de-novo palmoplantar and nail psoriasis complicating Nivolumab treatment for metastatic melanoma
Ambra Di Altobrando et al.
DERMATOLOGIC THERAPY (2020)
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature
Olga Nigro et al.
IMMUNOTHERAPY (2020)
Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism
Masamoto Murakami et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report
Maria Anna Siciliano et al.
FRONTIERS IN ONCOLOGY (2020)
NB-UVB phototherapy in the treatment of anti-PD-1 inhibitor induced psoriasis: A case report
Vincent T. Ma et al.
CURRENT PROBLEMS IN CANCER: CASE REPORTS (2020)
Three cases of IL36RN-associated pustulosis: An evolution of acrodermatitis continua of Hallopeau to generalized pustular psoriasis
Yun-Liu Chen et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2020)
Clinical and genetic differences between pustular psoriasis subtypes
Sophie Twelves et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast
Davide Fattore et al.
EUROPEAN JOURNAL OF CANCER (2019)
Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study
Ulrich Mrowietz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy
Daniel Johnson et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Gregory S. Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial
Tadashi Terui et al.
JAMA DERMATOLOGY (2019)
Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide
Adan Rios et al.
EUROPEAN JOURNAL OF CANCER (2019)
Psoriasis in Patients With Active Lung Cancer: Is Apremilast a Safe Option?
Zoe Apalla et al.
DERMATOLOGY PRACTICAL & CONCEPTUAL (2019)
Acrodermatitis continua of Hallopeau: clinical perspectives
Mary Patricia Smith et al.
PSORIASIS-TARGETS AND THERAPY (2019)
New onset of psoriasis during nivolumab treatment for lung cancer
Satomi Chujo et al.
JOURNAL OF DERMATOLOGY (2018)
Flare-up of pustular psoriasis after ustekinumab therapy: Case report and literature review
Ying-Xiu Dai et al.
DERMATOLOGICA SINICA (2018)
Initially undetected de novo psoriasis triggered by nivolumab for metastatic base of the tongue carcinoma
S. Troyanova-Slavkova et al.
HAUTARZT (2018)
Generalized pustular psoriasis: a review and update on treatment
K. M. Hoegler et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Anti-Programmed Cell Death-1-Induced Plaque and Guttate Psoriasis
Toshiyuki Yamamoto
INDIAN JOURNAL OF DERMATOLOGY (2018)
Psoriatic arthritis due to nivolumab administration a case report and review of the literature
Konstantinos Sapalidis et al.
RESPIRATORY MEDICINE CASE REPORTS (2018)
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy
Jonathan L. Curry et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Case of de novo psoriasis possibly triggered by nivolumab
Susumu Murata et al.
JOURNAL OF DERMATOLOGY (2017)
What do we know about palmoplantar pustulosis?
M. Misiak-Galazka et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Anti-PD1-induced psoriasis: a study of 21 patients
J. Bonigen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
TLN-58, an Additional hCAP18 Processing Form, Found in the Lesion Vesicle of Palmoplantar Pustulosis in the Skin
Masamoto Murakami et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade
Khashayar Esfahani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Anti-PD1/PDL1 induced psoriasis
Dimitra Voudouri et al.
CURRENT PROBLEMS IN CANCER (2017)
Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
Emma Guttman-Yassky et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome
Juan Ruiz-Banobre et al.
APMIS (2017)
Psoriasis and psoriatic arthritis induced by nivolumab (Opdivo®)
J. -L. Schmutz
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2016)
Ustekinumab in the treatment of palmoplantar pustular psoriasis - a case series of nine patients
Valeska Buder et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2016)
Psoriasis and psoriatic arthritis induced by nivolumab in a patient with advanced lung cancer
Sarah Law-Ping-Man et al.
RHEUMATOLOGY (2016)
Occurrence of Psoriasiform Eruption During Nivolumab Therapy for Primary Oral Mucosal Melanoma
Mikio Ohtsuka et al.
JAMA DERMATOLOGY (2015)
Acrodermatitis Continua of Hallopeau Is a Clinical Phenotype of DITRA: Evidence that It Is a Variant of Pustular Psoriasis
Ossama Abbas et al.
DERMATOLOGY (2013)
The Majority of Generalized Pustular Psoriasis without Psoriasis Vulgaris Is Caused by Deficiency of Interleukin-36 Receptor Antagonist
Kazumitsu Sugiura et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
分享论文
